3D Printed, Controlled Release, Tritherapeutic Tablet Matrix for Advanced Anti-HIV-1 Drug Delivery.

CONCLUSION: A 3DP FDC was successfully manufactured with the aid of a 3D-Bioplotter in a single step process. The versatile HA-PQ10 entrapped all drugs and achieved an enhanced relative bioavailability of EFV, TDF, and FTC compared to the market formulation for potentially enhanced HIV treatment. PMID: 29655904 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29655904?dopt=Abstract

Source: European Journal of Pharmaceutics and Biopharmaceutics - April 12, 2018 Category: Drugs & Pharmacology Authors: Siyawamwaya M, du Toit LC, Kumar P, Choonara YE, Kondiah PPPD, Pillay V Tags: Eur J Pharm Biopharm Source Type: research